1-8 of 8
Jing Xie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study

Clinical Trials & Observations
Adrian Minson, Nada Hamad, Chan Y. Cheah, Constantine Tam, Piers Blombery, David Westerman, David Ritchie, Huw Morgan, Nicholas Holzwart, Stephen Lade, Mary Ann Anderson, Amit Khot, John F. Seymour, Molly Robertson, Imogen Caldwell, Georgina Ryland, Javad Saghebi, Zahra Sabahi, Jing Xie, Rachel Koldej, Michael Dickinson
Journal: Blood
Blood (2024) 143 (8): 673–684.
https://doi.org/10.1182/blood.2023021306
Published: 2024
Includes: Supplemental data
Journal Articles

Obinutuzumab, Lenalidomide and Venetoclax in Patients with Treatment-Naïve Advanced-Stage Follicular Lymphoma: First Results of the Investigator-Initiated Phase Ib/II, Multicenter Leverage Study

Chan Y. Cheah, Katharine L. Lewis, Rory Bennett, Amanda Jane Johnston, Joel Wight, Jing Xie, Stella Vlahos, Katrina Celeste, Sally Binks, John F. Seymour
Journal: Blood
Blood (2023) 142 (Supplement 1): 1659.
https://doi.org/10.1182/blood-2023-184660
Published: 2023
Journal Articles

High Efficacy of Azacitidine Plus Hag in Acute Myeloid Leukemia: A Multi-Center, Phase 2 Clinical Trial

Jun Li, Qi Han, Yanqing Huang, Yanhui Wei, Jie Zi, Lidong Zhao, Zhimei Cai, Xuzhang Lu, Rong Xiao, Yanmin Zhang, Xiaotian Yang, Hao Xu, Naitong Sun, Wanchuan Zhuang, Zhengdong Wu, Yuan Xia, Yanli Xu, Bin He, Wei Zhu, Fengling Min, Yongchun Chen, Banghe Ding, Peimin Shi, Jing Xie, Hua Tang, Zefa Liu, Bingzong Li, Yu Sun, Hongxia Qiu, Limin Duan, Chunhua Song, Zheng Ge
Journal: Blood
Blood (2022) 140 (Supplement 1): 6167–6169.
https://doi.org/10.1182/blood-2022-164649
Published: 2022
Journal Articles

Time-Limited Ibrutinib and Tisagenlecleucel Is Highly Effective in the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma, Including Those with TP53 Mutated and Btki-Refractory Disease: First Report of the Tarmac Study

Adrian Minson, Nada Hamad, Chan Y. Cheah, Constantine S. Tam, Piers Blombery, David A Westerman, Stephen Lade, David Ritchie, Rachel M Koldej, Mary Ann Anderson, Amit Khot, John F. Seymour, Molly Robertson, Imogen R Caldwell, Georgina L Ryland, Jing Xie, Huw Morgan, Michael Dickinson
Journal: Blood
Blood (2022) 140 (Supplement 1): 181–183.
https://doi.org/10.1182/blood-2022-160459
Published: 2022
Journal Articles

Real-World Treatment Patterns and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in the UK: A Preliminary Analysis

Jing Xie, Alan Yong, Catherine Waweru, PhD, Thuy Anh Sorof, Ravi K Goyal, MS, Keith L Davis, MA, George Follows, Peter Hillmen, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5885.
https://doi.org/10.1182/blood-2019-123025
Published: 2019
Journal Articles

Clinical Characteristics & Outcome of Adolescent Patients with Acute Lymphoblastic Leukemia

Jiaole Yu, PhD MD, Ruidong Zhang, MD PhD, Jing Xie, MD, Yuanyuan Zhang, MD, Ying Wu, MD, Chao Gao, Wei Lin, Huyong Zheng, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5007.
https://doi.org/10.1182/blood.V130.Suppl_1.5007.5007
Published: 2017
Journal Articles

Pediatric Mixed Phenotype Acute Leukemia-41 Cases Report

Huifang Gao, Yi Liu, Ruidong Zhang, Jing Xie, Huiwen Shi, Minyuan Wu, Pengli Huang, Huyong Zheng
Journal: Blood
Blood (2012) 120 (21): 4811.
https://doi.org/10.1182/blood.V120.21.4811.4811
Published: 2012
Journal Articles

Effects of Imatinib and Rapamycin on the mTOR/S6 Signal Transduction Pathway in CD33 + Cell of CML

Guangsheng He, Jing Xie, Wu Depei, Xiang Zhang, Aining Sun
Journal: Blood
Blood (2008) 112 (11): 4228.
https://doi.org/10.1182/blood.V112.11.4228.4228
Published: 2008